Haixiang Pharmaceutical: Semi-Annual Financial Report
Haixiang Pharmaceutical: 2024 Semi-Annual Report Summary
Haixiang Pharmaceutical: Announcement on holding the 2024 semi-annual online results briefing
Haixiang Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Haixiang Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Haixiang Pharmaceutical: Company shares held by directors, supervisors and senior management and its change management system (revised in August 2024)
Haixiang Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Haixiang Pharmaceutical: 2024 Semi-Annual Report
Haixiang Pharmaceutical: Announcement on the Appointment of the Secretary of the Board
Haixiang Pharmaceutical: 2024 Semi-Annual Financial Report
Haixiang Pharmaceutical: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Zhejiang Hisoar Pharmaceutical: Announcement on Progress of Providing Guarantees to Subsidiaries within Consolidated Financial Statements.
Zhejiang Hisoar Pharmaceutical: Announcement on the completion of the implementation of the director's shareholding plan.
Zhejiang Hisoar Pharmaceutical: Announcement regarding the release of pledges on stocks by major shareholders.
Zhejiang Hisoar Pharmaceutical: Announcement regarding changes in directors and senior management personnel.
Zhejiang Hisoar Pharmaceutical: Announcement on stock pledged repurchase trade for partial stocks of major shareholders.
Zhejiang Hisoar Pharmaceutical: Announcement on the Progress of Investment in Henlius by Participating Partnership Enterprises.
Zhejiang Hisoar Pharmaceutical: May 20, 2024 Investor Relations Activity Schedule
Zhejiang Hisoar Pharmaceutical: An indicative announcement on the duration and sale of the 2020 Employee Stock Ownership Plan
Zhejiang Hisoar Pharmaceutical: Haixiang Pharmaceutical's 2023 Annual Shareholders' Meeting Witnessed Legal Opinions
No Data
No Data